OptimizeRx Corporation (OPRX)
USD 8.53
(4.22%)
USD 8.53
(4.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 56.82 Million USD | 565.32% |
| 2022 | 8.54 Million USD | -11.09% |
| 2021 | 9.6 Million USD | -7.23% |
| 2020 | 10.35 Million USD | -12.08% |
| 2019 | 11.77 Million USD | 78.53% |
| 2018 | 6.59 Million USD | 86.16% |
| 2017 | 3.54 Million USD | -3.36% |
| 2016 | 3.66 Million USD | 8.74% |
| 2015 | 3.37 Million USD | 39.4% |
| 2014 | 2.41 Million USD | 22.86% |
| 2013 | 1.96 Million USD | 189.53% |
| 2012 | 679.94 Thousand USD | -47.83% |
| 2011 | 1.3 Million USD | -29.73% |
| 2010 | 1.85 Million USD | 4803.06% |
| 2009 | 37.83 Thousand USD | -82.63% |
| 2008 | 217.79 Thousand USD | -44.14% |
| 2007 | 389.89 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 51.86 Million USD | -3.66% |
| 2024 Q1 | 53.82 Million USD | -5.27% |
| 2023 Q2 | 5.5 Million USD | -28.71% |
| 2023 Q3 | 7.82 Million USD | 41.98% |
| 2023 Q4 | 56.82 Million USD | 626.38% |
| 2023 Q1 | 7.72 Million USD | -9.5% |
| 2023 FY | 56.82 Million USD | 565.32% |
| 2022 Q3 | 6.3 Million USD | -4.97% |
| 2022 Q1 | 7.08 Million USD | -26.21% |
| 2022 Q2 | 6.63 Million USD | -6.45% |
| 2022 Q4 | 8.54 Million USD | 35.54% |
| 2022 FY | 8.54 Million USD | -11.09% |
| 2021 Q1 | 5.73 Million USD | -44.61% |
| 2021 Q3 | 7.83 Million USD | 12.73% |
| 2021 Q4 | 9.6 Million USD | 22.63% |
| 2021 FY | 9.6 Million USD | -7.23% |
| 2021 Q2 | 6.94 Million USD | 21.15% |
| 2020 Q1 | 12.61 Million USD | 7.08% |
| 2020 Q2 | 12.55 Million USD | -0.44% |
| 2020 FY | 10.35 Million USD | -12.08% |
| 2020 Q3 | 8.46 Million USD | -32.56% |
| 2020 Q4 | 10.35 Million USD | 22.29% |
| 2019 Q4 | 11.77 Million USD | 58.75% |
| 2019 FY | 11.77 Million USD | 78.53% |
| 2019 Q1 | 5.81 Million USD | -11.84% |
| 2019 Q2 | 7.72 Million USD | 32.89% |
| 2019 Q3 | 7.41 Million USD | -4.0% |
| 2018 Q4 | 6.59 Million USD | 158.03% |
| 2018 FY | 6.59 Million USD | 86.16% |
| 2018 Q1 | 2.43 Million USD | -31.17% |
| 2018 Q3 | 2.55 Million USD | -10.14% |
| 2018 Q2 | 2.84 Million USD | 16.64% |
| 2017 Q1 | 3.86 Million USD | 5.45% |
| 2017 Q2 | 4 Million USD | 3.68% |
| 2017 Q3 | 3.76 Million USD | -6.14% |
| 2017 Q4 | 3.54 Million USD | -5.83% |
| 2017 FY | 3.54 Million USD | -3.36% |
| 2016 Q2 | 2.84 Million USD | 11.36% |
| 2016 Q1 | 2.55 Million USD | -24.34% |
| 2016 Q3 | 3.22 Million USD | 13.36% |
| 2016 FY | 3.66 Million USD | 8.74% |
| 2016 Q4 | 3.66 Million USD | 13.85% |
| 2015 FY | 3.37 Million USD | 39.4% |
| 2015 Q1 | 2.18 Million USD | -9.84% |
| 2015 Q2 | 2.27 Million USD | 4.52% |
| 2015 Q3 | 3.08 Million USD | 35.13% |
| 2015 Q4 | 3.37 Million USD | 9.47% |
| 2014 Q1 | 1.91 Million USD | -2.84% |
| 2014 FY | 2.41 Million USD | 22.86% |
| 2014 Q4 | 2.41 Million USD | 58.86% |
| 2014 Q3 | 1.52 Million USD | 2.7% |
| 2014 Q2 | 1.48 Million USD | -22.49% |
| 2013 FY | 1.96 Million USD | 189.53% |
| 2013 Q1 | 751.2 Thousand USD | 10.48% |
| 2013 Q2 | 712.27 Thousand USD | -5.18% |
| 2013 Q3 | 757.72 Thousand USD | 6.38% |
| 2013 Q4 | 1.96 Million USD | 159.81% |
| 2012 Q2 | 1.02 Million USD | 7.91% |
| 2012 FY | 679.94 Thousand USD | -47.83% |
| 2012 Q4 | 679.94 Thousand USD | -23.62% |
| 2012 Q1 | 949.52 Thousand USD | -27.15% |
| 2012 Q3 | 890.25 Thousand USD | -13.11% |
| 2011 FY | 1.3 Million USD | -29.73% |
| 2011 Q1 | 1.87 Million USD | 1.07% |
| 2011 Q2 | 1.86 Million USD | -0.64% |
| 2011 Q3 | 739.44 Thousand USD | -60.3% |
| 2011 Q4 | 1.3 Million USD | 76.26% |
| 2010 Q2 | 620.77 Thousand USD | 4372.74% |
| 2010 FY | 1.85 Million USD | 4803.06% |
| 2010 Q4 | 1.85 Million USD | 195.63% |
| 2010 Q3 | 627.41 Thousand USD | 1.07% |
| 2010 Q1 | 13.87 Thousand USD | -63.31% |
| 2009 Q2 | 48.34 Thousand USD | -74.96% |
| 2009 Q1 | 193.07 Thousand USD | -11.35% |
| 2009 FY | 37.83 Thousand USD | -82.63% |
| 2009 Q4 | 37.83 Thousand USD | 221.11% |
| 2009 Q3 | 11.78 Thousand USD | -75.63% |
| 2008 FY | 217.79 Thousand USD | -44.14% |
| 2008 Q4 | 217.79 Thousand USD | 0.0% |
| 2007 FY | 389.89 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Streamline Health Solutions, Inc. | 22.92 Million USD | -147.844% |
| Augmedix, Inc. | 43.39 Million USD | -30.95% |
| CareCloud, Inc. | 37.79 Million USD | -50.331% |
| HealthEquity, Inc. | 1.2 Billion USD | 95.271% |
| iCoreConnect Inc. | 11.24 Million USD | -405.417% |
| Progyny, Inc. | 203.19 Million USD | 72.036% |
| Renalytix Plc | 15.82 Million USD | -259.034% |
| SOPHiA GENETICS SA | 54.71 Million USD | -3.85% |
| Omnicell, Inc. | 1.03 Billion USD | 94.526% |
| Ontrak, Inc. | 5.57 Million USD | -919.206% |
| Minerva Surgical, Inc. | 51.71 Million USD | -9.864% |
| Accolade, Inc. | 342.68 Million USD | 83.419% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 98.903% |
| CareCloud, Inc. | 37.79 Million USD | -50.331% |
| Health Catalyst, Inc. | 334.89 Million USD | 83.033% |
| HealthStream, Inc. | 159.19 Million USD | 64.306% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 95.5% |
| Nutex Health, Inc. | 319.13 Million USD | 82.196% |
| OneMedNet Corporation | 13.32 Million USD | -326.497% |
| Schrödinger, Inc. | 254.39 Million USD | 77.665% |
| Simulations Plus, Inc. | 14.2 Million USD | -299.921% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.774% |
| Sharecare, Inc. | 125.56 Million USD | 54.748% |
| Aclarion, Inc. | 3.18 Million USD | -1682.461% |
| CareMax, Inc. | 561.85 Million USD | 89.887% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -30722.199% |
| Forian Inc. | 33.19 Million USD | -71.165% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -30722.199% |
| HeartBeam, Inc. | 1.19 Million USD | -4658.855% |
| GeneDx Holdings Corp. | 245.65 Million USD | 76.87% |
| SCWorx Corp. | 2.42 Million USD | -2243.349% |
| Definitive Healthcare Corp. | 626.72 Million USD | 90.934% |
| 10x Genomics, Inc. | 224.1 Million USD | 74.645% |
| Zhongchao Inc. | 3.37 Million USD | -1581.846% |
| MSP Recovery, Inc. | 1.74 Billion USD | 96.736% |
| R1 RCM Inc. | 2.2 Billion USD | 97.428% |
| Spok Holdings, Inc. | 63.91 Million USD | 11.097% |
| Privia Health Group, Inc. | 392.51 Million USD | 85.524% |
| EUDA Health Holdings Limited | 8.79 Million USD | -546.245% |
| TruBridge, Inc. | 247.8 Million USD | 77.07% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 98.903% |
| Sharecare, Inc. | 125.56 Million USD | 54.748% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 93.128% |
| Premier, Inc. | 1.46 Billion USD | 96.125% |
| Certara, Inc. | 516.29 Million USD | 88.995% |
| GeneDx Holdings Corp. | 245.65 Million USD | 76.87% |
| Ontrak, Inc. | 5.57 Million USD | -919.206% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -55.298% |
| CareCloud, Inc. | 37.79 Million USD | -50.331% |
| EUDA Health Holdings Limited | 8.79 Million USD | -546.245% |
| HeartBeam, Inc. | 1.19 Million USD | -4658.855% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -20484.31% |
| CareMax, Inc. | 561.85 Million USD | 89.887% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -497.421% |
| National Research Corporation | 73.48 Million USD | 22.674% |
| Aclarion, Inc. | 3.18 Million USD | -1682.461% |